WHAT YOU NEED TO KNOW Last week, the JAMA Network published a must-read study which found that from 2007 to 2018, the net price of brand-name prescription drugs rose by 60 percent. First reported on by Axios, this study emphasizes the growing obstacle everyday Americans face when trying to afford the often lifesaving prescription drugs they need.  To […]

Continue Reading

WHAT YOU NEED TO KNOW U.S. Senator John Cornyn (R-TX) held a roundtable with Texas health professionals to discuss ways to lower prescription drug prices. Senator Cornyn highlighted the bipartisan legislation he introduced alongside Senator Richard Blumenthal (D-CT), the Affordable Prescriptions for Patients Act, which would rein in Big Pharma’s use of patent thickets and promote more […]

Continue Reading

WHAT YOU NEED TO KNOW During a hearing before the Senate Finance Committee, United States Secretary of Health and Human Services Alex Azar highlighted the need for legislation to address Big Pharma’s use of patent thickets to abuse the American patent system. “Just one drug alone the savings from biosimilar market entry would be billions of dollars […]

Continue Reading

IN CASE YOU MISSED IT: Yesterday, during testimony before the Senate Finance Committee and amid questioning from U.S. Senator John Cornyn (R-TX), United States Secretary of Health and Human Services Alex Azar urged Congress to act and finally address Big Pharma’s use of patent thickets to expand their monopolies and maintain their drug high prices. As […]

Continue Reading

WHAT YOU NEED TO KNOW With rising prescription drug prices at top of mind for many Americans, it’s continuing to receive attention on the campaign trail.  This week former New York City Mayor Mike Bloomberg released a new drug pricing plan that would tackle one of the biggest problems by reforming our nation’s broken patent system. Bloomberg’s plan limits […]

Continue Reading

WHAT YOU NEED TO KNOW Today, Roll Call published an op-ed by Matthew Lane, executive director of the Coalition Against Patent Abuse praising the ongoing bipartisan efforts to rein in Big Pharma’s abuse of the American patent system. “Finding common ground isn’t easy in today’s divided Washington. We are even seeing it in the broader drug pricing debate […]

Continue Reading

WHAT YOU NEED TO KNOW The Richmond Times Dispatch recently published an op-ed by Matthew Lane, executive director of the Coalition Against Patent Abuse praising the bipartisan efforts of Representatives Abigail Spanberger (D-VA) and Tom Reed (R-NY) to rein in Big Pharma’s patent abuse. “Spanberger and Reed’s bill would require drugmakers to disclose the patents that protect their biologic medications, […]

Continue Reading

WHAT YOU NEED TO KNOW On Thursday, Patients for Affordable Drugs (P4AD) released a report “The Truth About Insulin Prices” as part of a campaign for World Diabetes Day. The report shows how pharmaceutical companies have kept the prices of insulin artificially high by manipulating the patent system. The report notes that, “… insulin manufacturers have […]

Continue Reading

WHAT YOU NEED TO KNOW This Wednesday, the Senate Judiciary Subcommittee on Intellectual Property held a hearing on the need to strengthen patent quality and prevent the spread of low-quality and invalid patents, which have contributed in part to high drug prices. CAPA released a statement commending Sen. Tillis (R-NC) for holding this hearing and […]

Continue Reading

WHAT YOU NEED TO KNOW Thanks to the bipartisan efforts of U.S. Senators John Cornyn (R-TX) and Richard Blumenthal (D-CT), who are among those in both parties working to end Big Pharma’s exploitation of American patients, the big drug companies are on the defensive as support grows to address Big Pharma’s rampant patent abuse. On […]

Continue Reading